Exploring the Potential Mechanism of Xiaokui Jiedu Decoction for Ulcerative Colitis Based on Network Pharmacology and Molecular Docking

Abstract

Introduction. Network pharmacology is in line with the holistic characteristics of TCM and can be used to elucidate the complex network of interactions between disease-specific genes and compounds in TCM herbal medicines. Here, we investigate the pharmacological mechanism of Xiaokui Jiedu decoction (XJD) for the treatment of ulcerative colitis (UC). Methods. The Computational Systems Biology Laboratory Platform (TCMSP) database was searched and screened for the active ingredients of all drugs in XJD. The Uniport database was used to retrieve possible gene targets for the therapeutic effects of XJD. GeneCards, PharmGKB, TTD, and OMIM databases were used to retrieve XJD-related gene targets. A herb-compound-protein network and a protein-protein interaction (PPI) network were constructed, and hub genes were screened for Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses. Finally, molecular docking was performed to validate the interrelationship between disease target proteins and active drug components. Results. A total of 135 XJD potential action targets, 5097 UC-related gene targets, and 103 XJD-UC intersection gene targets were screened. The hub gene targets of XJD that exert therapeutic effects on UC are RB1, MAPK1, TP53, JUN, NR3C1, MAPK3, and ESR1. GO enrichment analysis showed 741 biofunctional enrichments, and KEGG enrichment analysis showed 124 related pathway enrichments. Molecular docking showed that the active components of XJD (β-sitosterol, kaempferol, formononetin, quercetin, and luteolin) showed good binding activities to five of the six hub gene targets. Discussion. The active ingredients of XJD (β-sitosterol, kaempferol, formononetin, quercetin, and luteolin) may regulate the inflammatory and oxidative stress-related pathways of colon cells during the course of UC by binding to the hub gene targets. This may be a potential mechanism of XJD in the treatment of UC.

Understanding the mechanism of Trikatu in type 2 diabetes mellitus and lipid-related metabolic disorders: A network pharmacology approach

“…Our docking results were corroborated by the previous NP studies that showed stable binding of RXRA with E-beta carotene (94) and piperlongumine as a direct inhibitor of STAT3 in cancer (95). In addition, beta-sitosterol also exhibits stable binding to ESR1 in a study related to ulcerative colitis (96).…”

Exploring the Mechanism of Yiqi Qingre Ziyin Method in Regulating Neuropeptide Expression for the Treatment of Atrophic Rhinitis

“…Codonopsis pilosula (20 g) was added to the prescription when patients presented with significant "qi" deficiency syndrome. In previous research, ingredients and targets of these herbs were downloaded from the traditional Chinese medicine systems pharmacology database [14][15][16][17]. An ingredient was defined as active when a combination of the following conditions was true: OB > 30% and DL > 0:18.…”

Mechanism of Zhinao Capsule in Treating Alzheimer’s Disease Based on Network Pharmacology Analysis and Molecular Docking Validation

“…Cui et al [ 15 ] reported that the active components of Huangqi Sijunzi decoction, including quercetin, luteolin, kaempferol, and naringenin, might exert therapeutic effects against cancer-related fatigue by suppressing inflammatory responses and the expression of tumor-related genes such as vascular endothelial growth factor A (VEGFA) and CASP3. Wang et al [ 16 ] found via network pharmacology that the active components of Xiaokui Jiedu decoction, such as β -sitosterol and quercetin, may alleviate ulcerative colitis by acting on multiple key targets to regulate oxidative stress-related pathways.…”